Estados financieros detallados de Cabaletta Bio, Inc. (CABA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $2.49, CABA presenta beneficios negativos (P/E no significativo) y un ROE del -128.27%. La capitalización bursátil es de $406M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | 0 | $4.5M | $11.7M | $21.4M | $32.5M | $39.3M | $55.4M | $97.2M | $142.7M |
| Generales y Administrativos | $250000 | $1.7M | $7.0M | $12.5M | $13.8M | $14.8M | $19.2M | $27.9M | $29.6M |
| Gastos Operativos | $250000 | $6.2M | $18.7M | $33.8M | $46.3M | $54.1M | $74.7M | $125.1M | $172.2M |
| Beneficio Operativo | -$250000 | -$6.2M | -$18.7M | -$33.8M | -$46.3M | -$54.1M | -$74.7M | -$125.1M | -$172.2M |
| EBITDA | $83333 | -$6.0M | -$18.6M | -$33.0M | -$45.6M | -$51.8M | -$66.2M | -$113.4M | -$164.2M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $748000 | $2.0M |
| Beneficio Antes de Impuestos | -$250000 | -$12.2M | -$16.9M | -$33.3M | -$46.3M | -$53.0M | -$67.7M | -$115.9M | -$167.9M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$250000 | -$12.2M | -$16.9M | -$33.3M | -$46.3M | -$53.0M | -$67.7M | -$115.9M | -$167.9M |
| BPA | $-0.01 | $-0.84 | $-4.07 | $-1.44 | $-1.80 | $-1.81 | $-1.65 | $-2.34 | $-1.64 |
| BPA Diluido | $-0.01 | $-0.84 | $-4.07 | $-1.44 | $-1.80 | $-1.81 | $-1.65 | $-2.34 | $-1.64 |
| Acciones en Circulación (Diluidas) | $24.0M | $14.5M | $5.5M | $23.1M | $25.7M | $29.3M | $40.9M | $49.5M | $102.3M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$46.6M | -$42.6M | -$44.3M | -$52.0M |
| EBITDA | -$43.9M | -$41.0M | -$42.5M | -$49.4M |
| Beneficio Neto | -$44.9M | -$41.9M | -$43.5M | -$51.0M |
| BPA | $-0.44 | $-0.41 | $-0.39 | $-0.34 |
| BPA Diluido | $-0.44 | $-0.41 | $-0.39 | $-0.34 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $1000 | $33.0M | $136.2M | $101.4M | $122.2M | $81.6M | $193.2M | $164.0M | $83.0M |
| Inversiones a Corto | 0 | 0 | 0 | $7.2M | 0 | $24.9M | $48.0M | 0 | $50.6M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $1000 | $34.0M | $140.6M | $113.5M | $124.5M | $108.8M | $244.5M | $166.7M | $138.9M |
| Inmovilizado Material | 0 | 0 | $815000 | $890000 | $1.4M | $7.6M | $7.5M | $16.1M | $21.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $1000 | $34.2M | $141.5M | $114.7M | $126.3M | $117.0M | $253.7M | $185.0M | $165.1M |
| Cuentas por Pagar | $189000 | $603000 | $920000 | $1.2M | $2.3M | $2.5M | $4.5M | $4.9M | $6.6M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $250000 | $943000 | $3.1M | $5.2M | $8.4M | $9.5M | $16.0M | $27.1M | $50.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.9M |
| Pasivos Totales | $250000 | $44.9M | $3.1M | $5.2M | $8.4M | $12.4M | $17.5M | $32.7M | $53.0M |
| Reservas | -$250000 | -$12.5M | -$33.0M | -$66.3M | -$112.6M | -$165.6M | -$233.2M | -$349.1M | -$517.0M |
| Patrimonio Neto | -$249000 | -$10.7M | $138.3M | $109.5M | $118.0M | $104.5M | $236.2M | $152.3M | $112.1M |
| Deuda Total | 0 | $43.9M | 0 | 0 | 0 | $5.1M | $5.0M | $15.6M | $27.1M |
| Deuda Neta | -$1000 | $10.9M | -$136.2M | -$108.7M | -$122.2M | -$101.4M | -$236.2M | -$148.4M | -$106.5M |
| Capital Circulante | -$249000 | $33.1M | $137.4M | $108.4M | $116.2M | $99.3M | $228.5M | $139.6M | $88.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $60.2M | $83.0M | $116.6M | $225.1M |
| Activos Totales | $189.8M | $165.1M | $148.1M | $256.7M |
| Pasivos Totales | $50.3M | $53.0M | $44.8M | $46.1M |
| Patrimonio Neto | $139.5M | $112.1M | $103.3M | $210.6M |
| Deuda Total | $25.8M | $27.1M | $26.4M | $25.7M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$333333 | -$12.2M | -$16.9M | -$33.3M | -$46.3M | -$53.0M | -$67.7M | -$115.9M | -$167.9M |
| Amortizaciones | 0 | 0 | $104000 | $354000 | $733000 | $1.2M | $1.4M | $1.7M | $1.6M |
| Compensación en Acciones | 0 | $606000 | $2.3M | $4.4M | $5.8M | $6.9M | $11.3M | $19.5M | $20.9M |
| Cambio en Capital Circulante | $81333 | -$464000 | -$1.5M | $1.7M | $5.6M | -$4.3M | $101000 | $1.6M | -$379000 |
| Flujo de Caja Operativo | 0 | -$4.7M | -$16.0M | -$26.8M | -$34.1M | -$46.4M | -$53.5M | -$88.2M | -$131.1M |
| Inversiones (CapEx) | 0 | 0 | -$693000 | -$635000 | -$1.2M | -$2.5M | -$687000 | -$2.2M | -$1.2M |
| Adquisiciones | 0 | 0 | 0 | $7346 | 0 | $24764 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | -$169000 | 0 | -$192000 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | -$10.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | 0 | -$4.7M | -$16.7M | -$27.4M | -$35.3M | -$48.8M | -$54.2M | -$90.4M | -$132.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$34.5M | -$35.3M | -$42.6M | -$41.5M |
| Inversiones (CapEx) | -$78000 | -$205000 | 0 | 0 |
| Flujo de Caja Libre | -$34.6M | -$35.5M | -$42.6M | -$41.5M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $5.8M | $4.3M | $5.3M | $5.5M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -4780.8% | -38.9% | -96.8% | -38.8% | -14.4% | -27.7% | -71.2% | -44.9% |
| Crecimiento BPA (anual) | | -7976.9% | -384.5% | +64.6% | -25.0% | -0.6% | +8.8% | -41.8% | +29.9% |
| Cambio en Acciones (anual) | | -39.6% | -62.3% | +323.2% | +11.2% | +14.0% | +39.5% | +20.8% | +106.7% |
| Crecimiento FCF (anual) | | | -259.1% | -63.7% | -28.7% | -38.4% | -11.1% | -66.7% | -46.3% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $0.00 | $-0.32 | $-3.06 | $-1.18 | $-1.37 | $-1.66 | $-1.32 | $-1.83 | $-1.29 |
| Dividendo por Acción | $0.00 | $0.00 | $1.84 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $24.0M | $14.5M | $4.2M | $23.1M | $25.7M | $29.3M | $40.9M | $49.5M | $102.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -128.27% |
| Rentabilidad sobre capital invertido | -78.51% |
| Rentabilidad sobre activos | -70.63% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.12 |
| Ratio corriente | 5.79 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -4.65 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -961.54 | -11.90 | -3.43 | -8.67 | -2.11 | -5.11 | -13.76 | -0.97 | -1.34 |
| P/VC | -965.22 | -13.58 | 0.42 | 2.64 | 0.83 | 2.60 | 3.94 | 0.74 | 2.00 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |